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Summary: We investigated the ability of meconium, fe-
ces from human milk-fed (HMF) newborns, and feces 
from formula-fed (FF) newborns to inhibit adhesion of 
S-fimbriated E. coli to human buccal epithelial cells. 
S-fimbriae are a common property of E.·coli strains caus-
ing sepsis and meningitis in neonates. Meconium had the 
highest content of neuraminic acid and the strongest in-
hibitory effect on bacterial adhesion. HMF also exerted 
high inhibitory activity while FF was markedly less ac-
tive: To achieve inhibitory effects comparable to HMF a 
sixfold amount of FF was required. Glycoproteins from 
excretions were separated by gel chromatography. Frac-
tions obtained were analyzed for adhesion-inhibiting ac-
Bacterial adhesion to mucosal epithelial surfaces 
is a prerequisite for manifestation of infections (1). 
Lectin-like adhesins on fimbriae mediate coloniza-
tion of eukaryotic tissues by recognizing carbohy-
drate receptors on their surface (2). 
N eonatal sepsis and meningitis are still major 
problems in pediatric infectious diseases. In a ret-
rospective study from 1981, E. coli was responsible 
for 30--40% of cases in the United States (3,4). 
S-fimbriae and K1 capsule type are major compo-
nents of E. coli strains causing sepsis and meningitis 
during the neonatal period (5). These adhesins bind 
to sialyl-a-2,3-galactoside str~ctures (6). 
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tivity. In all excretions analyzed, the mucin-containing 
fraction could be identified as the major inhibitory com-
ponent. Inhibition was probably mediated by specific in-
teraction of this fraction with S-fimbriae, as shown by 
binding of isolated fimbriae on Western blots after elec-
trophoretic separation of glycoproteins. In conclusion, 
our data support the view that the mucin-containing frac-
tion from meconium and human milk exerts antibacterial 
functions by preventing adhesin-mediated binding of 
pathogenic bacteria to mucosal epithelia. Key Words: 
S-fimbriated E. coli-Inhibition of adhesion-Me-
conium-Feces of human milk-fed newborns-Feces of 
formula-fed newborns-Mucins. 
In the newborn, the gastrointestinal tract and the 
oropharynx seem to be the reservoir for E. coli that 
can invade the bloodstream and, subsequently, the 
central nervous system (7-9). Meconium and feces 
of human milk-fed (HMF) infants have a high con-
tent of neuraminic acid-containing structures. We 
compared the ability of meconium and feces of hu-
man milk-fed and formula-fed (FF) newborns and 
different fractions of these materials to inhibit ad-
hesion of S-fimbriae carrying E. coli to human buc-
cal epithelial cells. 
MATERIALSAND METHODS 
Bacteria 
Adhesion experiments were carried out with E. 
coli strain HB 101 carrying the recombinant plasmid 
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(pANN 801-4) that encodes S-fimbriae (10). In a few 
preliminary experiments, strain IH 3084 (kindly 
provided by Dr. Korhonen, U niversity of Helsinki, 
Finland), isolated from a newborn with meningitis 
and carrying S-fimbriae, was used. Since expres-
sion of S-fimbriae in this strain was unstable in 
vitro, this strain did not appear tobe useful for fur-
ther experiments. 
Bacteria were grown on NB agar supplemented 
with 0.1% glucose and tetracycline (30 1-Lg/ml). After 
an 18 h incubation period at 37°C, bacteria were 
harvested with ice-cold 20 mM sodium borate 
bufferat pH 9.0 and washed twice with the same 
buffer. Following adjustment to 1010 bacteria/ml, 1 
ml of the suspension was labeled with 100 1-Lg of 
fluorescein isothiocyanate (FITC, Sigma Chemieals 
Co., St. Louis, MO, U .S.A.) as described by Park-
kinen et al. (11). The expression of S-fimbriae in the 
strains was confirmed by inhibition assays as pre-
viously described (12). 
Isolation of Buccal Epithelial Cells 
Buccal epithelial cells (BECs) were obtained 
from healthy adult nonsmokers by scraping mucosa 
with a spoon-shaped spatula several times. Cells 
were washed off the spatula with phosphate-
buffered saline (PBS) containing 0.1% bovine serum 
albumin (BSA) and 0.5% methyl-~-o-mannoside, 
washed three times, and microscopically adjusted 
to 1 x 105 cells/ml. 
Binding of Bacteria to Buccal Epithelial Cells and 
Preincubation of Bacteria with Inhibitors 
Five hundred microliters of bacterial suspension 
or bacteria/inhibitor mixtures adjusted to 1 x 108 
cells/ml was added to an equal volume of BEC sus-
pension ( 1 x 105 /ml) and incubated for 60 min in an 
ice bath under gentle shaking. Epithelial cells were 
washed three times with PBS (centrifugation for 5 
min at 4°C and 120 x g) before microscopic evalu-
ation. Fifty epithelial cells were analyzed for each 
experiment. All experiments were done in dupli-
cate. 
For inhibition studies, bacteria were preincu-
bated with potential inhibitors for 15 min in an ice 
bath under gentle shaking. Inhibitor concentnltions/ 
volumes stated below refer to the 15 min preincu-
bation period. 
The following inhibitors and volumes were used: 
meconium samples were collected from five new-
borns (first excretion, first day). One gram (wet 
weight) of each sample was homogenized and di-
luted in 15 ml of 0.9% NaCl. After centrifugation 
(5,000 x g) to remove solid components, the super-
natant was fittered through a paper filter and diluted 
with six parts ofNaCl. Forty, 80, 160, and 320 j..Lllml 
of inhibitor mixtures were used. The same proce-
dure was applied to feces from five human milk-fed 
and five formula-fed (adapted, Pre Aptamil, Milupa, 
Germany) newborns (6 days of age). 
For other inhibition experiments, 200,' 400, 800, 
and 1,000 1-Lg of the glycoprotein fractions from 
meconium, HMF, and FF per 1 ml of inhibitor mix-
ture were tested. These fractions were obtained af-
ter phenol-saline extraction of excretions with sub-
sequent dialysis against distilled water (48 h, 4°C) 
and lyophilization (13). 
The content of N-acetylneuraminic acid (NeuAc) 
and protein of each sample (raw suspension and 
sialoglycoprotein fraction) for the inhibition assay 
were determined according to Warren (14) and 
Lowry, respectively (15). Furthermore, 38 meco-
nium, 17 HMF, and 18 FF samples were analyzed. 
As controls, asialoglycoproteins were prepared 
from the glycoprotein fractions by acid hydrolysis 
(0.1 M HCI at 80°C for 1 h) and used in the binding 
assay. 
Gel Chromatography of Sialoglycoproteins 
Lyophilized sialoglycoproteins were sepanited 
according to their size on a Sephacryl S-300 column 
(100 x 2.5 cm), eluted with 4 M guanidine hydro-
chloride, pH 7 .0, containing 1 mM ethylenedi-
amine-tetraacetic acid (EDTA) and 1 mM Na2P04 • 
Five milliliter fractions were collected. Carbohy-
drate~ were detected in aliquots by the phenolsul-
furic acid procedure of Dubois et al. (16) at 485 nm. 
Additionally, the protein content was recorded by 
spectrometry at 280 nm. 
Pooled peak fractions were dialyzed against H20, 
lyophylized, and then used at different concentra-
tions as inhibitors in the binding assay. Aliquots of 
these fractions were further analyzed by sodium do-
decyl sulfate-polyacrylamide gel electrophoresis 
(SDS-P AGE) and · staining with Coomassie blue 
(CB), periodic acid-Schiff reagent (PAS), and 
wheat germ agglutinin (WGA). The content of 
NeuAc (14) and protein (15) was determined. 
Isolation and Purification of S-Fimbriae 
S-fimbriae were isolated essentially according to 
the procedure described by Salit and Gotschlich 
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(17) with the modification ofWevers et al. (18). The 
purity (homogeneity) of the preparation was con-
firmed by SDS-P AGE and examination by electron 
microscopy. 
Western Blot Analysis with Isolated Fimbriae 
Glycoproteins were separated (by PAGE) after 
preincubation in 100 tJ.l of sample buffer containing 
0.3% SOS and 3% 2-mercaptoethanol for 10 min at 
90°C. For WGA staining, 1 mg was used, and for 
binding of purified fimbriae, 3 mg was used. Elec-
trophoresis of sialoglycoproteins from meconium, 
HMF, and FF was performed in polyacrylamide 
gels (3-13%) in the presence of SDS (0 .1%). Gels 
were fixed and stained with CB or PAS reagent. 
Electroblotting onto nitrocellulose (0.45 tJ.ffi) was 
performed in Tris (25 mM), glycine (192 mM), and 
methanol (20%). 
For WGA staining, the nitrocellulose membranes 
were immersed in PBS at pH 7.2 containing 5% 
(wlv) BSA to block nonspecific binding sites and 
overlayed with a solution of WGA-peroxidase con-
jugate (5-10 tJ.g/ml) diluted in 0.5% BSA/PBS. After 
incubation for 1 h at room temperature and three 
successive washing steps (0.5% BSA/PBS), the 
membranes were developed in PBS/methanol ( 17% 
v/v) containing 1-chloro-4-naphthol (0.055%) and 
hydrogen peroxide (0.008%). Optimum staining was 
obtained after 30 min in the dark. 
For binding of purified fimbriae to transblots, the 
strips wete blockedas mentioned above. Next, the 
membranes were overlayed with fimbriae sus-
pended in PBS (125 J.Lg ofprotein/ml) for 17 hat 4°C. 
For immunostaining, membranes were incubated 
for 1 hat 4°C with monoclonal antibody A 21356 Al 
(1:1,000) (kindly provided by Dr. K. Jann), which 
recognizes S-fimbriae (19). After washing, alkaline 
phosphatase-conjugated rabbit anti-mouse IgG 
(1: 1 ,000) (Dako, Hamburg, Germany) was added 
for 30 min at room temperature and washed four 
times with PBS. Membranes were developed with 
5-bromo-4-chloro-3-indolylphosphatf! s.odium salt 
and Nitro blue tetrazolium chloride (Serva, Heidel-
berg, Germany) for 15 min at 37°C. 
RESULTS 
Adhesion of S-Fimbriated E. coli to Human 
· Buccal Cells 
Fluorescence microscopy of buccal epithelial 
cells after incubation with FITC-labeled S-fimbri-
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ated E. coli strain HB 101 (pANN 801-4) showed 
that 15-30 bacteria had bound to one epithelial cell 
if no inhibitorwas used (12). Binding characteristics 
of the clinical isolate IH 3084 to buccal epithelia did 
not differ from that of the cloned strain HB 101 
(pANN 801-4) (data not shown). 
Content of N-Acetylneuraminic Acid and Protein in 
Meconium, HMF, and FF 
The NeuAc and protein content of meconium, 
HMF, and FF are shown in Table 1. In all raw 
excretions, 20-25% of NeuAc was free neuraminic 
acid, and the restwas glycoconjugate bound. 
Inhibition of Bacterial Adhesion to Human Buccal 
Epithelial Cells by Meconium, HMF, and FF 
Figure IA shows that the strengest inhibitory ef-
. fect on adhesion of cloned S-fimbriated E. coli to 
human buccal epithelial cells was exerted by meco-
nium, and the weakest by FF. In order to achieve 
40% inhibition, 40 ~I of meconium preparation was 
required. Comparable inhibitory effects of HMF re-
quired twice the volume, and FF a 12-fold greater 
volume. 
Figure 1 B shows a similar relationship between 
the N euAc content and the extent of adhesion inhi-
bition for both meconium and HMF. For FF, in 
contrast, a two- to threefold high er N euAc concen-
tration is required to achieve comparable inhibitory 
effects. 
U sing isolated glycoprotein fractions from meco-
nium, HMF and FF inhibition in relation to the 
NeuAc concentration resembled the FF raw prep-
aration (data not shown). 
TABLE 1. Content ofN-acetylneuraminic acid and 
protein in meconium, HMF, and FF 
NeuAc (mg/g of Protein (mg/g of 
Raw meconium 
(n = 43) 
Raw human milk feces 
(n = 22) 
Raw formula feces 
(n = 23) 
a Means ± SO are given. 
wet weight)b wet weight)c 
15.2 ± 2.6 3.5 ± 5.4 
7.9 ± 2.6 1.2 ± 5.4 
3.4 ± 1.4 1.9 ± 6.9 
b NeuAc was measured according to Warren (14). 
c Protein was measured by the Lowry method (15) using bo-
vine serum albumin (BSA) as standard. 
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FIG. 1. Inhibition of bacterial adhesion [E. coli HB 101 (pANN 801-4)] to human buccal epithelial cells by raw preparations of 
meconium and feces of breast-fed and formula-fed newborns. A: Inhibition of bacterial adhesion in relation to the volume of raw 
preparations. B: Inhibition of bacterial adhesion in relation to the NeuAc concentration. For preparation of the suspension, refer 
to the Materialsand Methods section. Means and standard deviations are given, n = 5. Four hundred eighty microliters was used 
additionally, because with lower volumes less than 40% inhibition was achieved (n = 3}. The NeuAc content of each stool 
preparation was calculated from five measurements: meconium, 746 ± 33 tJ.Q/ml; HMF, 385 ± 114 fl.Q/ml; FF, 200 ± 62 ~g/ml. 
Volumes of stool preparations refer to 1 ml of inhibition mixture. 
Desialination reduced the ability of glycoproteins 
(1 mg/ml) to inhibit adhesion to 10-15%. 
Gel Chromatography of Glycoproteins 
The major peaks (A-C) obtained after gel chro-
matography of feces glycoproteins were pooled sep-
arately, as shown in Fig. 2A-C. Pooled fractions 
were dialyzed against distilled water and ly-
ophilized. A and C were tested for inhibitory activ-
ity in the bacteria binding assay. Concentrations of 
inhibitors leading to approximately 50% inhibition 
of bacterial adhesion are shown in Table 2. 
High-molecular-weight fraction A (void volume 
>200 kDa) showed the strongest inhibitory activity. 
Using pooled fractions of A, 50% inhibition could 
be achieved with 250 tJ.g/ml (meconium) or 500 tJ.gl 
ml (HMF and FF). For pooled fractions of C, 750 
tJ.g/ml of inhibition mixture was required. The ab-
solute NeuAc content offraction A was in the range 
of 5-16% of fraction C. Sialinization, however, of 
glycoproteins in fraction A with a NeuAc/protein 
ratio of 20: 1-~60: 1 was markedly higher compared 
to fraction C with a ratio of 1:1-1.3:1. 
Pooled fractions were further analyzed by SDS-
PAGE and Western blot (Fig. 3). Staining of the 
gels with CB and PAS of pools A revealed high-
molecular-mass glycoproteins (>200 kDa) positive 
for PAS but negative for CB. This band was WGA 
positive on Western blot analysis and was thus clas-
sified as mucin because of molecular mass and 
staining behavior. Fraction C was also negative for 
CB staining and showed weak PAS- and WGA-
positive bands corresponding to sialoglycoprQteins 
of lower molecular weight. Blots of meconium frac-
tions are shown. Similar staining behavior was seen 
with HMF and FF fractions. The staining pattern of 
pool B was comparable to pool C (data not shown). 
Binding of Isolated S-Fimbriae to Transblots 
In order to characterize better the major compo-
nent responsible for adhesion inhibition, isolated 
fimbriae were incubated with nitrocellulose strips 
containing separated glycoproteins (Fig. 4). Fim-
briae predominantly bound to the WGA- and PAS-
positive mucin-containing bands. 
DISCUSSION 
Wehave recently shown that S-fimbriated E. coli 
plays a major role in neonatal sepsis and meningitis 
(5) by adhering to human buccal epithelial cells (12). 
In the present study, we investigated the ability of 
meconium, HMF, and FF to inhibit adhesion of 
S-fimbriated E. coli to epithelial cells. 
The most relevant system to study such antiad-
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FIG. 2. Gel chromatography profile (Sephacryl S-300) of 
glycoproteins from meconium, HMF, and FF. Absorbance 
was measured at 280 nm () and 485 nm (0-0). Eluted frac-
tions were pooled as indicated: A: 50 mg pooled from first 
five excretions was applied; B: 40 mg of pooled stools from 
five breast-fed 6-day-old newborns was applied; C: 60 mg of 
pooled stools from five formula-fed 6-day-old newborns 
was applied. 
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TABLE 2. Fifty percent inhibition of bacterial adhesion 
to human buccal epithelial cells by pooled glycoprotein 
fractions (A-C) of meconium, HMF, and FF after gel 
chromatography on Sephacryl S-3ooa 
Neu Ac Protein 
concentration of concentration of 
inhibitor present in inhibitor present in 
Inhibitor inhibition mixture inhibition mixture 
(~g/ml) (~g/ml) (~glml) 
Meconium 
Pool A, 250 13.9 
Pool B,c nd 
Pool C, 750 78.8 60.6 
Human milk feces 
Pool A, 500 9.3 0.5 
Pool B, 750 18.3 16.1 
Pool C, 750 63.5 67.0 
Formula feces 
Pool A, 500 15.2 0.5 
Pool B, 750 41.8 15.3 
Pool C, 750 102.0 83.8 
a Means of duplicate determinations are given. 
b Below the detection limit9fthe Lowry method (15), i.e., <I 
J,~.g/ml. 
c Pool B could only be analyzed for the content of N-acetyl-
neuraminic acid (56.9 J,~.g/ml) and protein (10.0 J,~.g/ml) because 
little material was obtained. 
hesive properties of excretions would, of course, be 
viable intestinal epithelia from newborns. Unfortu-
nately, these are difficult to obtain·. Human intesti-
nal celllines as a possible alternative undergo mor-
phological and functional changes after a few pas-
sages in tissue culture (20). 
Adhesive properties of a given bacterial strain 
vary depending on tissues used (21). We used buc-
cal epithelial cells for two reasons: first, oral epi-
thelia are an easily accessible part of the gastroin-
testinal tract and, second, the oropharynx and the 
intestine both serve as a natural entry route for in-
vasive pathogenic E. coli (7 ,9). Adhesion of S-fim-
briated E. coli to buccal epithelial cells is, similarly 
to type I fimbriae-carrying E. coli, age independent 
(22,23). Therefore, epithelial cells from adults were 
used as a model to study bacterial adhesion. 
Meconium in our study showed the highest inhib-
itory activity against adhesion of S-fimbriated E. 
coli to buccal epithelial cells. Its high content of 
neuraminic acid-containing glycoproteins with 
0-linked carbohydrate chains of the mucin type is 
weil known (24-27). 
The mucin-containing fraction from meconium, 
HMF, and FF are the major components in glyco-
protein fractions separated by gel chromatography 
(pool A) for both inhibition of bacterial adhesion 
and binding of isolated fimbriae to trans blots. 
Smaller sialoglycoproteins (pool C < 60,000 MG), 
in this respect, play only a minor role. Meconium 
mucins originate from fetal intestine and swaflowed 
amniotic fluid mucins (28), HMF mucins from in-
testine and milk (29 ,30), and FF mucins from intes-
tine only (31). 
The anti-infectious potential of mucins in the pre-
vention of bacterial adhesion to epithelial tissues 
has been documented in recent sturlies (32,33,34). 
This particular function of mucins is related to their 
unique structural properties, especially to their con-
jugated and often highly sialylated carbohydrates, 
which express a multitude of receptor-analogous 
1 2 3 4 
FIG. 3. Polyacrylamide gel electrophoresis and Western blot 
anatysis of pooled fractions A and C of HMF glycoproteins 
separated by gel chromatography (see Fig. 28). Fraction A: 
lanes 1 and 2; fraction C: lanes 3 and 4. Freeze-dried sam-
ples containing 30 I-L9 of protein (Lowry) per lane were ap-
plied. Lanes 1 and 3 are gels stained with PAS; lanes 2 and 4 
are Western blots, stained with WGA. Rainbow protein mo-
lecular weight markers (Amersham, Braunschweig, Ger-
many) were used as standards. 
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2 3 4 5 6 7 8 9 
FIG. 4. Binding of WGA and S-fimbriae to glycoproteins after separation by SOS-PAGE and blotting to nitrocellulose. Lanes 1-3 
contain glycoproteins from meconium, lanes 4-6 contain glycoproteins from stools of breast-fed newborns, and lanes 7-9 
contain glycoproteins from stools of formula-fed newborns. Lanes 1, 4, and 7 are gels stained with PAS; lanes 2, 5, and 8 are 
Western blots stained with WGA; and lanes 3, 6, and 9 are immunostained for S-fimbriae after incubation with nitrocellulose 
strips as described in the Materialsand Methods section. Rainbow protein molecular weight markers (Amersham, Braunschweig, 
Germany) were used as standard. 
structures for bacterial adhesins. Recently, it has 
been reported that in receptor-binding assays, milk 
fat globule mucins have inhibitory activity against 
human immunodeficiency virus (35). 
Neeser et al. (36,37) have been able to demon-
strate a significant inhibitory effect of meconium 
glycopeptides on colonization factor antigen (CFA) 
I and 11-mediated hemagglutination by E. coli and 
CFA 11-mediated adhesion to the enterocyte-like 
differentiated HT 29. Although adhesins of CF A I 
and li complexes also recognize neuraminic acid-
containing structures (38), meconium preparations 
used in the experiments of Neeser et al. (36,37) 
were able to inhibit hemagglutination or adhesion to 
HT 29 cells even after desialination. This finding is 
in contrast to our results obtained with S-fimbriated 
E. coli: desialination of glycoproteins from all 
sources markedly reduced the adhesion-inhibiting 
capacity by 85-90%. 
On ~iochemical analysis of the stool prepara-
tions, we noticed that raw preparations of meco-
nium and HMF had similar inhibitory activities on 
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the basis of their NeuAc content. In contrast, raw 
preparations of FF with comparable NeuAc con-
centrations were two- to threefold less active in 
comparison to meconium and HMF. U sing isolated 
glycoproteins from meconium, HMF, and FF, this 
difference was markedly less pronounced. Compo-
nents other than the glycoprotein fractions may be 
responsible for this effect, e.g., neuraminic acid-
containing glycolipids or oligosaccharides that were 
not recovered during the process of glycoprotein 
preparation (39-41). This would also explain differ-
ences between the N euAc content of raw prepara-
tions and glycoproteins. However, in earlier studies 
[Schroten et al. (23)], we were able to show that the 
oligosaccharide fraction from human milk does not 
inhibit adhesion of S-fimbriated E. coli to buccal 
epithelial cells. 
After separation of glycoproteins, the mucin-
containing high-molecular-weight fraction A of all 
stool preparations was most effective with respect 
to inhibition of bacterial adhesiqn. This finding cor-
relates weil with the high degree of sialination of 
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glycoproteins in fraction A (approximately 20- to 
60-fold compared to fraction C). Predominantly, 
neuraminic acid covalently linked to mucins corre-
lated with the inhibitory effect, not the total (includ-
ing nonmucin) neuraminic acid content. These mu-
cins are constituents of the glycoprotein fraction. 
lf equal volumes of meconium and HMF were 
assayed for adhesion-inhibiting capacity, meconium 
was clearly more effective. This could, at least in 
part, be due to the higher content of mucin-bound 
neuraminic acid. FF exhibited little inhibitory ef-
fects compared to meconium and HMF. This can-
not be solely explained by the known low content of 
neuraminic acid in raw material ( 42). Structural dif-
ferences of mucins in different excretions could 
play a role in addition to their relative content in the 
glycoprotein fraction. 
The results presented in this study support the 
view that mucins present in breast milk contribute 
to antibacterial mechanisms present along the entire 
intestine. 
Acknowledgment: This project was supported by Deut-
sche Forschungsgemeinschaft Sehr 281/3-2. 
REFERENCES 
1. Beachy EH. Bacterial adherence: adhesin-receptor interac-
tions mediating the attachment of bacteria to mucosa sur-
faces. J Jnfect Dis 1981 ;143:325-45. 
2. Orskov I, Orskov F. Escherichia coli in extraintestinal in-
fections. J Hyg Camb 1985;95:551-75. 
3. Freedman RM, Ingram DL, Gross I, Ehrenkranz RA, War-
shaw JB, Saltimore RS. A half century of neonatal sepsis at 
Yale 1928-1978. Am J Dis Child 1981;135:140-4. 
4. Glode MP, Sutton A, Robbins JM, et al. Neonatal meningitis 
due to Escherichia coli Kl. J lnfect Dis 1977;16:93-7. 
5. Korhonen TK, Valtonen MV, Parkkinen J, et al. Serotypes, 
hemolysin production and receptor recognition of Escheri-
chia coli strains associated with neonatal sepsis and menin-
gitis. Infect Immun 1985;48:486-91. 
6. Korhonen TK, Väisänen-Rhen V, Rhen M, Pere A, Park-
kinen J, Finne J. Escherichia coli fimbriae recognizing sialyl 
galactosides. J Bacteriol 1984;159:762-6. 
7. Guerina NG, Kessler TW, Guerina VJ, et al. The role of pili 
and capsule in the pathogenesis of neonatal infection with 
Escherichia coli Kl. J lnfect Dis 1983;148:395-405. 
8. Klein JO, Marcy SM. Bacterial sepsis and meningitis. In: 
Remington JS, Klein JO, eds. lnfectious diseases of the fe-
tus and newborn. Philadelphia: W.B. Saunders, 1990:601-
56. 
9. SarffLD, McCracken GH. Epidemiology of Escherichia coli 
K1 in healthy and diseased newborns. Lancet 1975;i: 1099-
104. 
10. Hacker J, Schmidt G, Hughes C, Knapp S, Marget M, 
Goebel W. Cloning and characterization ofgenes involved in 
production of mannose-resistant, neuraminidase susceptible 
(x) fimbriae from a uropathogenic 06:K15:H31 Escherichia 
coli strain. Irifect Immun 1985;47:434-40. 
11. Parkkinen J, Korhonen TK, Pere A, Hacker J, Soinila S. 
Binding sites in the rat brain for Escherichia co/i S-fimbriae 
associated with neonatal meningitis. J Clin lnvest 1988;81: 
860-5. 
12. Schroten H, Wolske A, Plagmann R, et al. Binding of cloned 
S-fimbriated E. coli to human buccal epithelial cells-
different inhibition of binding by neonatal saliva and adult 
saliva. Zbl Bakterio/1919;274:514-8. 
13. Klenk E, Uhlenbruck G. Über neuraminsäurehaltige Mu-
coide aus Menschenerythrocytenstroma: ein Beitrag zur 
Chemie der Agglutinogene. Hoppe Seylers Z Phys Chem 
1960;319: 151-60. 
14. Warren L. The thiobarbituric acid assay of sialic acids. J 
Biol Chem 1959;234:1971-5. 
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein 
. measurement with the folin phenol reagent. J Bio/ Chem 
1951 ;193:265-75. 
16. Dubois M, Gilles K, Hamitton JK, Rebers PA, Smith F. 
Colorimetric method for determination of sugars and related 
substances. Anal Chem 1956;28:350-6. 
17. Salit IE, Gotschlich EC. Remagglutination by purified type 
I Escherichia co/i pili. J Exp Med 1977;146:1169-81. 
18. Wevers P, Picken R, Schmidt G, et al. Characterization of 
pili associated with E. coli 018ac./nj'ect Immun 1980;29:685-
91. 
19. Moch T, Hoschützky H, Hacker J, Kröncke KD, Jann K. 
Isolation and characterization of the a-sialyl-ß-2,3-galac-
tosyl-specific adhesin from fimbriated Escherichia coli. Proc 
Natl Acad Sei USA 1987;84:3462-6. 
20. Deneke CF, McGowan K, Thorne GM, Gorbach SL. At-
tachment of enterotoxigenic Escherichia coli to human in-
testinal cells. Infect Immun 1983;20:1102-6. 
21. Varian SA, Cooke EM. Adhesive properties of Escherichia 
co/i from urinary-tract infections. J Med Microbioli980;13: 
111-9. 
22. Clegg H, Guerina N, Langermann S, Woodrow-Kessler T, 
Guerina V, Goldmann D. Pilus-mediated adherence of Es-
cherichia coli K1 to human oral epithelial cells. Infect Im-
mun 1984;45:299-301. 
23. Schroten H, Steinig M, Plagmann R, et al. S-Fimbriae me-
diated adhesion of Eschericha coli to human buccal epithe-
lial cells is age dependent. lnfection (subrnitted for publica-
tion). 
24. Capon C, Leroy Y, Wieruszeski JM, et al. Structures of 
0-glycosidically linked oligosaccharides isolated from hu-
man meconium glycoproteins. Eur J Bioehern 1989;182:139-
52. 
25. Fraser D, Clamp JR. The glycoprotein content ofmeconium. 
Clin Chim Acta 1975;59:301-7. 
26. Hounsell EF, Lawson AM, Feeney J, et al. Structural anal-
ysis of the 0-glycosidically linked core-region oligosaccha-
rides of human meconium glycoproteins whic~ express on-
cofoetal antigens. Eur J Bioehern 1985;148:367-77. 
27. Odin L. Sialic acid in human serum protein and in meco-
nium. Acta Chem Scand 1955;9:862-4. 
28. Arcilla MB, Sturgeon P. Lewis and ABH substances in am-
niotic fluid obtained by amniocentesis. Pediatr Res 1972;6: 
853-8. 
29. Hanisch FG, Peter-Katalinic J, Egge H, Dabrowski U, 
Uhlenbruck G. Structures of acidic 0-linked polylactosami-
noglycans on human skim milk mucins. Glycoconjugate J 
1990;7:525-43. 
30. Schroten H, Plagmann R, Hanisch FG, Hacker J, Uhlen-
bruck G, Wahn V. Inhibition of adhesion of S-fimbriated E. 
coli to buccal epithelial cells by human milk fat globule mem-
brane mucins: a new aspect of protective function of the 
non-immunoglobuline fraction [Abstract]. Pediatr Res 1990; 
28:298. 
31. Neutra MR, Forstner JF. Gastrointestinal rnucus: synthesis, 
secretion and function. In: Johnson LR, ed. Physiology of 
J Pediatr Gastroenterol Nutr, Vol. 15, No. 2, 1992 
158 H. SCHROTEN ET AL. 
the gastrointestinal tract, 2nd edition. New York: Raven 
Press, 1987:975-1009. 
32. Mantle M, Basaraha L, Peacock SC, Gall DG. Binding of 
Yersinia enterocolitica to rabbit intestinal brush border 
membranes, mucus and mucin. Infect Immun 1989;57: 
3292-9. 
33. Drumm B, Roherton AM, Sherman PM. Inhibition ofattach-
ment of Escherichia coli RDEC-1 to intestinal microvillus 
membranes by rabbt ileal mucus and mucin in vitro. Infect 
Immun 1988;56:2437-42. 
34. Sanford BA, Thomas VL, Ramsay MA. Binding of staphy-
lococci to mucus in vivo and in vitro. Infect Immun 1989; 
57:3735-42. 
35. Newburg DS, Linhardt R, Peterson J, Ellis L, Hamosh M, 
Yolken RH. The human milk inhibitors of HIV binding [Ab-
stract]. Pediatr Res 1991 ;29: 1064. 
36. Neeser JR, Chambaz A, Hoang KY, Link-Amster H. 
Screening for complex carbohydrates inhibiting hemaggluti-
nations by CFA/1- and CFA/11-expressing enterotoxigenic 
Escherichia coli strains. FEMS Microbiol Lett 1988;49: 
301-7. 
37. Neeser JR, Chambaz A, Golliard M, Link-Amster H, Fryder 
V, Kolodziejczyk E. Adhesion of colonization factor antigen 
J Pediatr Gastroenterol Nutr, Vol. 15, No. 2, 1992 
II positive enterotoxigenic Escherichia coli strains to human 
enterocytelike differentiated HT-29 cells: a basis for host-
pathogen interactions in the gut. Infect Immun 1989;57: 
3727-34. 
38. Wadström T. Sialic acid specific bacteriallectins of entero-
toxigenic Escherichia co/i (ETEC) and Campylobacter py-
lori: an overview. Interleesymposium (in press). 
39. Sabharwal H, Sjöblad S, Lundblad A. Sialylated oligosac-
charides in human milk and feces of preterm, full-term, and 
weaning infants. J Pediatr Gastroenterol Nutr 1991;12: 
480-4. 
40. Sahbarwal H, Sjöblad S, Lundblad A. Affinity chromato-
graphic identification and quantitation of blood group A-ac-
tive oligosaccharides in human milk and feces of breast-fed 
infants. J Pediatr Gastroenterol Nutr 1991 ;12:474-9. 
41. Iwamori N, Noguchi M, Yamamoto T, Yago M, Nozawa S, 
Nagai Y. Selective terminal a2-3 and a2-6 sialylation of gly-
cosphingolipids with Iacto-series type I and 2 chains in hu-
man meconium. FEBS Lett 1988;233: 134-8. 
42. Schmidt E. Vergleichende Untersuchungen über den 
Neuraminsäuregehalt im Serum und Stuhl bei frauenmiteh-
und kuhmilchernährten Neugeborenen und Säuglingen. Z 
Kinderheilkd 1963;88:122-9. 
